Guangde has been the Editor of BMC Anesthesiology since 2016 and is based in the Shanghai office. Before joining BioMed Central, Guangde received his BSc in theoretical physics from Nanjing University, China and his PhD in quantum chemistry from the Royal Institute of Technology, Sweden. When he was graduated, he came back to China as an assistant researcher investigating the growth of composite membranes for water processing, before moving on to study the growth of solid tumors using computer simulation. His interest then turned to medial science and he worked as medical editor for a number of years before joining BioMed Central as an editor of BMC series.
Matthias Eikermann is a clinician-scientist and educator with a strong interest in clinical research and implementation science. He has an established research portfolio in perioperative respiratory physiology, critical care and sleep medicine, with an additional interest in drug development.
In his capacities of the clinical director of quality improvement and research in the critical care division, and Medical Director of respiratory care at MGH, Dr. Eikermann orchestrated the development of perioperative treatment guidelines in collaboration with surgery, nursing, physical therapy, respiratory care, and physical medicine and rehabilitation. He built an interdisciplinary high performing team of ICU nurses, physical therapists, rehabilitation physicians, trauma and thoracic surgeons, as well as ICU physicians to develop the “SICU Optimal Mobility Strategy” (SOMS) for goal-directed early mobilization, an important innovation that has been adopted at 2 MGH ICUs, as well as other hospitals in the US and in Europe (UMASS, BIDMC in New England, Klinikum Rechts der Isar in Munich, Germany, Salzburg University Hospital, Austria, Spedali Civili University Hospital, Brescia, Italy).
Pain management and analgesia
Prof. Patrice Forget, M.D. Ph.D., attended medical school at the Université catholique de Louvain (UCL). He is anesthesiologist teaching and taking patients in charge in the operating room and the chronic pain management unit at the Universitair Ziekenhuis Brussel (UZ Brussel).
He is involved in clinical research, studying pain and the impact of surgery and anesthetic drugs (non-steroidal anti-inflammatory drugs) on cancer outcomes at the Vrije Universiteit Brussel (VUB). For the last ten years, as main investigator and/or national coordinator, he published more than 100 articles, letters and/or abstract. He is vice-president of the Belgian Pain Society, Cochrane and REDCap consortia member.
He joined BMC Anesthesiology in 2014 as Associate Editor, and in 2015 as Section Editor.
General pharmacology and pharmacokinetics
Dr. Jun Lin is an attending physician in Anesthesiology at Stony Brook University Hospital and a faculty member at State University of New York at Stony Brook School of Medicine. Dr. Lin completed his medical education, graduate study in pharmacology and residency in medicine at Sun Yat-sen University, Guangzhou, China. He was awarded a Ph.D. in Biomedical Science at Mount Sinai School of Medicine, New York and a M.D. from State University of New York. Dr. Lin conducted his Residency training in Anesthesiology at Montefiore Medical Center/Albert Einstein College of Medicine and is a Diplomate of American Board of Anesthesiology.
Dr. Lin has been elected to the Association of University Anesthesiologists in 2016 and has served on national committees including American Society of Anesthesiologists (ASA) Abstract Review Subcommittee on Anesthetic Action and Biochemistry, ASA Educational Track Subcommittee on Ambulatory Anesthesia, Postgraduate Assembly in Anesthesiology PGA Sub-Committee on Residents Research Contest.
In addition to clinical work, Dr. Lin has led his own research group and publish extensively. His research includes novel effects and mechanisms of anesthetics, ion channel physiology and pharmacology, and cancer pharmacology.